These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 19200841

  • 1. Novel prophylactic and therapeutic vaccine against tuberculosis.
    Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Nakatani H, Takao K, Kishigami C, Inoue Y, Matsumoto M, McMurray DN, Dela Cruz EC, Tan EV, Abalos RM, Burgos JA, Saunderson P, Sakatani M.
    Vaccine; 2009 May 26; 27(25-26):3267-70. PubMed ID: 19200841
    [Abstract] [Full Text] [Related]

  • 2. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 26; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of a novel vaccine (HVJ-liposome/HSP65 DNA+IL-12 DNA) against tuberculosis using the cynomolgus monkey model of TB.
    Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Fukamizu R, Tsunai Y, Inoue R, Nakatani H, Namie Y, Yamada J, Takao K, Asai R, Asaki R, Matsumoto M, McMurray DN, Dela Cruz EC, Tan EV, Abalos RM, Burgos JA, Gelber R, Sakatani M.
    Vaccine; 2007 Apr 20; 25(16):2990-3. PubMed ID: 17280753
    [Abstract] [Full Text] [Related]

  • 5. DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation.
    Yoshida S, Tanaka T, Kita Y, Kuwayama S, Kanamaru N, Muraki Y, Hashimoto S, Inoue Y, Sakatani M, Kobayashi E, Kaneda Y, Okada M.
    Vaccine; 2006 Feb 20; 24(8):1191-204. PubMed ID: 16216394
    [Abstract] [Full Text] [Related]

  • 6. Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model.
    Kita Y, Tanaka T, Yoshida S, Ohara N, Kaneda Y, Kuwayama S, Muraki Y, Kanamaru N, Hashimoto S, Takai H, Okada C, Fukunaga Y, Sakaguchi Y, Furukawa I, Yamada K, Inoue Y, Takemoto Y, Naito M, Yamada T, Matsumoto M, McMurray DN, Cruz EC, Tan EV, Abalos RM, Burgos JA, Gelber R, Skeiky Y, Reed S, Sakatani M, Okada M.
    Vaccine; 2005 Mar 18; 23(17-18):2132-5. PubMed ID: 15755583
    [Abstract] [Full Text] [Related]

  • 7. Novel therapeutic vaccine: granulysin and new DNA vaccine against Tuberculosis.
    Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Nakatani H, Takao K, Kishigami C, Nishimatsu S, Sekine Y, Inoue Y, Matsumoto M, McMurray DN, De la Cruz EC, Tan EV, Abalos RM, Burgos JA, Saunderson P, Sakatani M.
    Hum Vaccin; 2011 Mar 18; 7 Suppl():60-7. PubMed ID: 21546794
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S, Hai Z, Limei W, Jiaze A, Li X, Tingfen Z, Zhikai X, Yong Z.
    Tuberculosis (Edinb); 2009 Jan 18; 89(1):54-61. PubMed ID: 19056317
    [Abstract] [Full Text] [Related]

  • 9. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep 18; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 10. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
    Wang LM, Bai YL, Shi CH, Gao H, Xue Y, Jiang H, Xu ZK.
    APMIS; 2008 Dec 18; 116(12):1071-81. PubMed ID: 19133010
    [Abstract] [Full Text] [Related]

  • 11. Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice models.
    Kita Y, Okada M, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Nakatani H, Takao K, Kishigami C, Nishimatsu S, Sekine Y, Takamori Y, McMurray DN, De la Cruz EC, Tan EV, Abalos RM, Burgos JA, Saunderson P, Sakatani M.
    Hum Vaccin; 2011 Dec 18; 7 Suppl():108-14. PubMed ID: 21263229
    [Abstract] [Full Text] [Related]

  • 12. [The development of novel vaccines against tuberculosis].
    Okada M.
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct 18; 31(5):356-68. PubMed ID: 18974619
    [Abstract] [Full Text] [Related]

  • 13. The study of novel DNA vaccines against tuberculosis: induction of pathogen-specific CTL in the mouse and monkey models of tuberculosis.
    Okada M, Kita Y, Nakajima T, Hashimoto S, Nakatani H, Nishimatsu S, Nishida Y, Kanamaru N, Kaneda Y, Takamori Y, McMurray D, Tan EV, Cang ML, Saunderson P, Dela Cruz EC.
    Hum Vaccin Immunother; 2013 Mar 18; 9(3):515-25. PubMed ID: 23249543
    [Abstract] [Full Text] [Related]

  • 14. Novel therapeutic vaccines [(HSP65 + IL-12)DNA-, granulysin- and Ksp37-vaccine] against tuberculosis and synergistic effects in the combination with chemotherapy.
    Kita Y, Hashimoto S, Nakajima T, Nakatani H, Nishimatsu S, Nishida Y, Kanamaru N, Kaneda Y, Takamori Y, McMurray D, Tan EV, Cang ML, Saunderson P, Dela Cruz EC, Okada M.
    Hum Vaccin Immunother; 2013 Mar 18; 9(3):526-33. PubMed ID: 23249609
    [Abstract] [Full Text] [Related]

  • 15. The treatment of mice infected with multi-drug-resistant Mycobacterium tuberculosis using DNA vaccines or in combination with rifampin.
    Liang Y, Wu X, Zhang J, Li N, Yu Q, Yang Y, Bai X, Liu C, Shi Y, Liu Q, Zhang P, Li Z.
    Vaccine; 2008 Aug 18; 26(35):4536-40. PubMed ID: 18602439
    [Abstract] [Full Text] [Related]

  • 16. Preclinical study and clinical trial of a novel therapeutic vaccine against multi-drug resistant tuberculosis.
    Okada M, Kita Y, Hashimoto S, Nakatani H, Nishimastu S, Kioka Y, Takami Y.
    Hum Vaccin Immunother; 2017 Feb 18; 13(2):298-305. PubMed ID: 27960629
    [Abstract] [Full Text] [Related]

  • 17. A Novel Therapeutic and Prophylactic Vaccine (HVJ-Envelope / Hsp65 DNA + IL-12 DNA) against Tuberculosis Using the Cynomolgus Monkey Model.
    Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nishida Y, Nakatani H, Takao K, Kishigami C, Nishimatsu S, Sekine Y, Inoue Y, Nagasawa T, Kaneda Y, Yoshida S, Matsumoto M, Paul S, Tan EV, Cruz ECD, N McMurray D, Sakatani M.
    Procedia Vaccinol; 2010 Feb 18; 2(1):34-39. PubMed ID: 32288910
    [Abstract] [Full Text] [Related]

  • 18. [Recent progress in mycobacteriology].
    Okada M, Kobayashi K.
    Kekkaku; 2007 Oct 18; 82(10):783-99. PubMed ID: 18018602
    [Abstract] [Full Text] [Related]

  • 19. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
    Gao H, Li K, Yu S, Xiong S.
    Microbiol Immunol; 2009 Oct 18; 53(10):541-9. PubMed ID: 19780967
    [Abstract] [Full Text] [Related]

  • 20. The immunogenicity and protective efficacy of Mtb8.4/hIL-12 chimeric gene vaccine.
    Li H, Li R, Zhong S, Ren H, Zou Y, Chen X, Shi X, Wang M, Long H, Luo Y.
    Vaccine; 2006 Feb 27; 24(9):1315-23. PubMed ID: 16219397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.